New infusion drug AION-301 aims to slow kidney disease progression

NCT ID NCT06721143

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether two infusions of AION-301 are safe and can reduce symptoms or slow the worsening of Stage 3 chronic kidney disease. About 36 adults will receive either AION-301 or a placebo, along with oral vitamins, and be followed for up to 24 months. The main goal is to check for side effects and see if the drug helps lower protein in the urine.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGE 3) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • SouthCoast Research Center, Inc.

    RECRUITING

    Miami, Florida, 33136, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Miami, Leonard M. Miller School of Medicine

    RECRUITING

    Miami, Florida, 33136, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••